Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M27,518Revenue (TTM) $M1,226Net Margin (%)-8.7Altman Z-Score25.1
Enterprise Value $M27,047EPS (TTM) $-0.6Operating Margin %-2.0Piotroski F-Score4
P/E(ttm)--Beneish M-Score0.4Pre-tax Margin (%)-9.4Higher ROA y-yN
Price/Book28.510-y EBITDA Growth Rate %--Quick Ratio2.7Cash flow > EarningsY
Price/Sales21.35-y EBITDA Growth Rate %--Current Ratio2.7Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %-113.2ROA % (ttm)-7.3Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-23.4Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M205ROIC % (ttm)-7.6Gross Margin Increase y-yN

Gurus Latest Trades with INCY

Number of guru portfolios checked: 68.
Ticker Guru Date Action
Impact Price Range
Current Price Change from Average Comment Current Shares

INCY is held by these investors:

INCY: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
BIENAIME JEAN JACQUESDirector 2017-05-15Buy500$11516.85view
Huber Reid MEVP, Chief Scientific Officer 2017-05-08Sell8,577$119.2112.73view
Trower PaulPrincipal Accounting Officer 2017-05-05Sell3,000$121.710.42view
Flannelly Barry PEVP & General Manager US 2017-05-01Sell5,296$124.737.74view
Siegel Eric H.EVP, General Counsel 2017-05-01Sell1,820$124.737.74view
BIENAIME JEAN JACQUESDirector 2017-04-28Buy500$124.268.14view
GRYSKA DAVID WExecutive Vice President, CFO 2017-04-28Sell1,389$124.268.14view
BIENAIME JEAN JACQUESDirector 2017-04-13Buy1,000$139.66-3.78view
Siegel Eric H.EVP, General Counsel 2017-04-10Sell4,043$140.18-4.14view
GRYSKA DAVID WExecutive Vice President, CFO 2017-04-10Sell41,528$138-2.62view

Quarterly/Annual Reports about INCY:

News about INCY:

Articles On GuruFocus.com
CORRECTING and REPLACING -- Merus Announces Fourth Quarter and Full Year 2016 Financial Results and May 03 2017 
Eaton Vance Worldwide Health Sciences Fund 1st Quarter Investment Report May 02 2017 
Lifshitz & Miller LLP Announces Investigation of Amyris, Inc., Commvault Systems, Inc., ICU Medical, Apr 28 2017 
Merus Announces Fourth Quarter and Full Year 2016 Financial Results and Corporate Developments Apr 28 2017 
SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Incyte Corporation Apr 20 2017 
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Incyte Corporati Apr 19 2017 
FDA Rejects Eli Lilly, Incyte's Commercialization Application Apr 18 2017 
Weekly CFO Sells Highlight Apr 17 2017 
U.S. FDA Issues Complete Response Letter for Baricitinib Apr 14 2017 
Incyte Insider Trims Position Apr 12 2017 

More From Other Websites
ETFs with exposure to Incyte Corp. : May 26, 2017 May 26 2017
Blog Coverage: Amgen Announces New Data from the FOURIER Trial May 23 2017
Incyte to Present at Upcoming Investor Conferences May 22 2017
Incyte Was the S&P 500’s Top Gainer on May 18 May 22 2017
Cramer's lightning round: I've got a message for the struggling Gilead Sciences May 19 2017
Bristol-Incyte Match Beats Dow's Merck In Combination Trials May 19 2017
Biotech Breakout Ahead? Incyte Rising On Success With Merk, Bristol-Myers May 19 2017
Company News for May 19, 2017 May 19 2017
The Most Notable Abstracts Released Ahead Of ASCO 2017 May 19 2017
Mercadolibre, Inc. Called a Great Growth Stock and Incyte Corporation Rockets on Positive... May 19 2017
Where buyers flock after a sell-off May 18 2017
Incyte (INCY) Announces Positive Data on Enzyme Inhibitor May 18 2017
Incyte Teams Up With Dow's Merck To Trounce Roche In Cancer May 18 2017
The Hot Stock: Incyte Climbs May 18 2017
Incyte Shares Vault After 'IDO' Cancer Immunotherapy Combo Data Revealed May 18 2017
Concert Pharma Falls After Clinical Hold on Hair Loss Drug May 18 2017
A $25 billion biotech's stock is popping on its promising cancer data May 18 2017
US STOCKS-Trump slump set to extend into second day May 18 2017
US STOCKS-Futures fall as Trump tumult continues May 18 2017

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)